Lipoprotein (a), hypertension, and cardiovascular outcomes: a prospective study of patients with stable coronary artery disease

Lipoprotein (a), hypertension, and cardiovascular outcomes: a prospective study of patients with stable coronary artery disease

Although emerging data suggest that circulating lipoprotein (a) [Lp (a)] could predict cardiovascular events (CVEs) in patients with cardiovascular disease, no study is currently available regarding the prognostic linkage of Lp (a) and hypertension in patients with coronary artery disease (CAD). Thi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension research 2021-09, Vol.44 (9), p.1158-1167
Hauptverfasser: Liu, Hui-Hui, Cao, Ye-Xuan, Jin, Jing-Lu, Hua, Qi, Li, Yan-Fang, Guo, Yuan-Lin, Zhu, Cheng-Gang, Wu, Na-Qiong, Dong, Qian, Li, Jian-Jun
Format: Artikel
Sprache:eng
Schlagworte:
Biomarkers
Cardiovascular disease
Clinical outcomes
Coronary Artery Disease
Coronary vessels
Humans
Hypertension
Hypertension - complications
Hypertension - epidemiology
Lipids
Lipoprotein(a)
Myocardial Infarction
Prospective Studies
Proteins
Risk Factors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Although emerging data suggest that circulating lipoprotein (a) [Lp (a)] could predict cardiovascular events (CVEs) in patients with cardiovascular disease, no study is currently available regarding the prognostic linkage of Lp (a) and hypertension in patients with coronary artery disease (CAD). This study sought to evaluate the association of Lp (a), hypertension and cardiovascular outcomes in patients with stable CAD. A total of 8668 patients with stable CAD were consecutively enrolled. Baseline Lp (a) concentrations were measured. All subjects were categorized according to Lp (a) levels of
ISSN:0916-9636
1348-4214
DOI:10.1038/s41440-021-00668-4